| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0054 | 1 |